Studies suggest that MPLC accounts for 0.2–20% of lung cancer ( 1 – 4 ), with an increasing trend attributed to improved diagnostic techniques and increased survival of patients with early stage lung cancer ( 8 , 15 , 16 ).
← all excerpts
Adenocarcinoma and squamous cell carcinoma in the same lobe of the lung with adenocarcinoma metastasis in the lymph nodes: a case report and literature review.
1
—
—